Chief Financial

GMP for CFOs

Quality budgets lose to other budgets because they are described as expenses. They are more accurately avoided costs — and avoided costs are only visible before they happen. This section is about making the exposure legible in the language finance already uses.

Why it reaches you

Understand the financial exposure GMP risk creates, and how to appraise the investment that removes it.

The headline risk everyone quotes — a recall, a suspended licence — is rare, and because it is rare it is easy to discount. The routine cost is duller and considerably larger: investigation labour, QA oversight on ageing corrective actions, working capital sitting in held batches, and the same problem solved twice. Those are lines a finance function recognises immediately once someone puts them on a page.

The reason they usually are not on a page is that they are distributed. Investigation hours sit in operational labour. Held stock sits in working capital. Rework sits in yield. No single line item says 'cost of poor quality', so the total is never assembled and the quality investment case is argued against zero rather than against the status quo.

Cost also escalates rather than accumulates. An open deviation costs investigation hours. A recurrence costs the same investigation twice. An overdue corrective action costs oversight and management attention. A held batch costs working capital and a customer conversation. An inspection finding costs a remediation programme on a deadline set by a regulator. Each stage moves control of the timeline further away from you, which is the part that should interest a CFO most.

The comparison that matters for capability is not consulting fees against zero. It is fees against the fully loaded cost of carrying the capability in-house: salary and overhead for specialists used a few weeks a year, the recruitment cycle, months to competence, key-person concentration, and the work that silently does not happen while one generalist covers four specialisms.

What you are accountable forWhere GMP lands on this desk specifically.
Quantifying an exposure nobody has totalled
The costs are real and already being paid; they are simply distributed across lines that do not name them.
Appraising the quality investment case
Comparing a remediation budget against twelve months of carrying cost, not against zero.
Working capital in held stock
Batch value multiplied by days held is a financing cost that rarely appears in a quality discussion.
Financial due diligence on GMP
Validation debt, CAPA backlogs and inspection history are liabilities that survive a transaction.
Not funding the wrong thing
A ranked, costed diagnosis prevents spending on the gap that was easiest to describe rather than the one carrying exposure.
Early signalsThese appear in data you already have, before anyone external sees them.

What to watch, in your own reporting

Quality spend is rising but outcomes are not improving

Usually means effort is going to intake rather than to the causes generating it.

Recurring costs with no owner

Rework, held stock and investigation labour absorbed as normal operating cost rather than tracked as avoidable.

Capital deferred on validated equipment

Validation debt is paid at the worst moment — during a transfer, a scale-up, or an inspection.

A remediation project appears with an external deadline

By this point the cost is set by someone else's timeline, which removes most of your options.

Questions worth askingIf any of these cannot be answered without a project, that is itself the answer.

Six questions that surface exposure early

  1. 01What did we spend on deviation investigation last year, in loaded hours?
  2. 02What is the average value and average hold duration of a batch held pending investigation?
  3. 03How much of our quality spend goes to solving problems we have already solved once?
  4. 04If we funded the current remediation proposal, what carrying cost does it remove — and over what period?
  5. 05What is our exposure concentrated in one person, and what would replacing them cost in time as well as salary?
  6. 06Are we appraising quality spend against zero, or against what the status quo costs?
One GMP problem. Multiple perspectives.Each links through to the technical article and to the other three perspectives.

Six GMP topics, read from the CFO chair

CAPA

What is a backlog of open corrective actions costing?

Technical article

The same problem, paid for twice

Each unclosed action carries QA oversight and management attention while it ages, and each recurrence costs the full investigation again. The cost is distributed across operational labour rather than appearing as a line item, which is why it is rarely totalled and rarely funded against.

Model the carrying cost of the current backlog against the remediation budget being proposed. The comparison is not spend against zero.

Data integrity

What is the exposure if this is found?

Technical article

Scope expands beyond the finding

Because the finding questions the reliability of records generally, remediation rarely stays contained to the system where it was found. Retrospective review, system remediation and re-validation across an estate is a materially larger programme than fixing one audit trail.

Fund the inventory and audit trail review programme before a finding sets the scope. Pre-emptive scope is chosen; post-finding scope is negotiated.

Inspection readiness

What does an unprepared inspection cost?

Technical article

The response runs on someone else's deadline

Preparation deferred until an inspection is announced costs the same work at a higher price, because it competes with normal operations under time pressure. A finding then converts a quality problem into a remediation programme with a fixed external deadline and, for a published outcome, a commercial cost as well.

Continuous readiness is the cheaper financing decision. The comparison is a modest recurring cost against a large unplanned one you do not control the timing of.

Deviations

What does each investigation actually cost?

Technical article

Loaded hours, multiplied by recurrence

An investigation consumes QA and technical hours at loaded rates, and a recurring event consumes them again. Where a batch is held pending the outcome, working capital sits idle for the duration at a financing cost that is rarely attributed to quality.

Model deviation volume, investigation hours and repeat rate together. The recurrence premium is usually the line that changes the conversation.

Validation

Is under- or over-validation costing more?

Technical article

Both directions are expensive

Under-validated, you cannot demonstrate the process does what you claim. Over-validated, you have built a maintenance obligation that consumes the team on every change — which then creates pressure to avoid improvements that would pay for themselves.

Scope validation to the risk each system actually carries. Uniform rigour is both expensive and, paradoxically, a way of under-controlling what matters.

Supplier and CMO risk

What is the financial shape of this dependency?

Technical article

Cheapest supplier, most expensive failure

Supplier selection optimised on unit cost alone ignores the cost of qualification failure: rejected material, investigation, held stock, expedited replacement and, where it reaches the market, recall assessment.

Weight qualification depth and audit history into sourcing decisions rather than treating them as a quality overhead applied afterwards.

Tools for this roleBoth calculate in your browser and submit nothing.

Move from reading to a position

Next step

Establish the position before deciding the response

The readiness score covers seven quality-system domains in twenty questions and names the two areas carrying most of your exposure. It calculates in your browser and submits nothing.